Codiak Biosciences Inc (CDAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CDAK | AZN | AMGN | GILD | BMY |
| Company | Codiak Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1100 | 163.79 | 393.36 | 136.00 | 64.81 |
| High | 0.1100 | 163.95 | 396.30 | 136.75 | 65.08 |
| Low | 0.0532 | 162.77 | 391.00 | 135.02 | 64.64 |
| Last | 0.0570 | 162.05 | 411.99 | 134.37 | 63.78 |
| Change | -0.0725 | +6.43 | +21.97 | -0.88 | -2.11 |
| Percent Change | -55.98% | +4.13% | +5.63% | -0.65% | -3.20% |
| Volume | 14,634,700 | 1,728,981 | 653,044 | 1,294,546 | 551,530 |
| 20-Day Average Volume | 4,001,600 | 3,885,029 | 2,397,213 | 6,107,353 | 12,470,785 |
| Previous | 0.1295 | 155.62 | 390.02 | 135.25 | 65.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3831 | 168.27 | 373.63 | 132.24 | 61.64 |
| 20-Day Raw Stochastic | 0.67% | 38.33% | 84.11% | 72.31% | 70.23% |
| 20-Day Relative Strength | 25.80 | 42.08 | 63.69 | 57.71 | 63.17 |
| Weighted Alpha | -91.75 | -0.01 | +36.61 | +14.27 | +42.04 |
| Today's Opinion | 100% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Yesterday's Opinion | 100% Sell | 100% Sell | 100% Buy | 40% Buy | 96% Buy |
| Last Month's Opinion | 72% Sell | 24% Buy | 72% Buy | 16% Sell | 16% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -70.00% since 03/28/23 | -5.55% since 07/29/26 | +0.87% since 07/29/26 | +3.22% since 07/29/26 | +2.58% since 07/29/26 |
| Low | 0.0532 on 04/04/23 | 153.41 on 08/03/26 | 375.96 on 08/03/26 | 128.28 on 07/30/26 | 62.23 on 07/30/26 |
| High | 0.2100 on 03/30/23 | 171.89 on 07/30/26 | 391.03 on 08/03/26 | 137.01 on 08/05/26 | 68.10 on 08/03/26 |
| 1-Month | |||||
| %Chg | -89.75% since 03/03/23 | -16.12% since 07/02/26 | +4.50% since 07/02/26 | +4.37% since 07/02/26 | +11.35% since 07/02/26 |
| Low | 0.0532 on 04/04/23 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 56.49 on 07/06/26 |
| High | 0.6200 on 03/17/23 | 193.79 on 07/07/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 3-Month | |||||
| %Chg | -88.93% since 01/04/23 | -9.69% since 05/05/26 | +18.63% since 05/05/26 | +2.64% since 05/05/26 | +13.66% since 05/05/26 |
| Low | 0.0532 on 04/04/23 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 0.9378 on 02/03/23 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 6-Month | |||||
| %Chg | -93.16% since 10/04/22 | -12.54% since 02/05/26 | +6.31% since 02/05/26 | -8.27% since 02/05/26 | +8.75% since 02/05/26 |
| Low | 0.0532 on 04/04/23 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 0.9600 on 11/02/22 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 68.10 on 08/03/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,099 | 241,352,288 | 210,496,928 | 167,922,336 | 134,594,496 |
| Shares Outstanding, K | 36,830 | 1,550,908 | 539,708 | 1,241,570 | 2,042,715 |
| Annual Sales, $M | 22,940,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | -37,160,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | 28,000 | 15,384,000,000 | 8,618,000,000 | 6,960,000,000 | 12,973,000,000 |
| Last Qtr Income, $M | -19,278,000 | 2,507,000,000 | 1,819,000,000 | 2,021,000,000 | 3,317,000,000 |
| 60-Month Beta | 3.71 | 0.26 | 0.41 | 0.32 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.77 on 11/03/22 | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 05/04/23 | 11/05/26 | 08/04/26 | 08/04/26 | 10/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.27 | 17.14 | 15.67 | 10.06 |